+Follow
Debit Card FAQ
No personal profile
2
Follow
1
Followers
2
Topic
0
Badge
Posts
Hot
Debit Card FAQ
2025-07-05
mona
$Bit Digital, Inc.(BTBT)$
$Synopsys(SNPS)$
Debit Card FAQ
2025-07-05
$Microsoft(MSFT)$
$Microsoft(MSFT)$
Debit Card FAQ
2025-07-05
Share your opinion about this news…
US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy
Debit Card FAQ
2025-07-04
Share your opinion about this news…
Sorry, the original content has been removed
Go to Tiger App to see more news
{"i18n":{"language":"en_US"},"userPageInfo":{"id":"4214681225167932","uuid":"4214681225167932","gmtCreate":1751578033160,"gmtModify":1751597170338,"name":"Debit Card FAQ","pinyin":"debitcardfaqdebitcardfaq","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":2,"tweetSize":0,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":2,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"init","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":453399477670296,"gmtCreate":1751715325402,"gmtModify":1751717187030,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4214681225167932","idStr":"4214681225167932"},"themes":[],"htmlText":"mona<a href=\"https://ttm.financial/S/BTBT\">$Bit Digital, Inc.(BTBT)$ </a><a href=\"https://ttm.financial/S/SNPS\">$Synopsys(SNPS)$ </a> ","listText":"mona<a href=\"https://ttm.financial/S/BTBT\">$Bit Digital, Inc.(BTBT)$ </a><a href=\"https://ttm.financial/S/SNPS\">$Synopsys(SNPS)$ </a> ","text":"mona$Bit Digital, Inc.(BTBT)$ $Synopsys(SNPS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/453399477670296","isVote":1,"tweetType":1,"viewCount":1166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":453398394003528,"gmtCreate":1751715253743,"gmtModify":1751717187509,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4214681225167932","idStr":"4214681225167932"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a> ","listText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a> ","text":"$Microsoft(MSFT)$ $Microsoft(MSFT)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/453398394003528","isVote":1,"tweetType":1,"viewCount":1421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":453173952565384,"gmtCreate":1751660628884,"gmtModify":1751664241117,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4214681225167932","idStr":"4214681225167932"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/453173952565384","repostId":"1159455215","repostType":4,"repost":{"id":"1159455215","kind":"news","pubTimestamp":1751637548,"share":"https://ttm.financial/m/news/1159455215?lang=en_US&edition=fundamental","pubTime":"2025-07-04 21:59","market":"us","language":"en","title":"US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy","url":"https://stock-news.laohu8.com/highlight/detail?id=1159455215","media":"Bloomberg","summary":"The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid...","content":"<div>\n<p>The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-04 21:59 GMT+8 <a href=https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVS":"诺华","PFE":"辉瑞","MRNA":"Moderna, Inc.","LLY":"礼来","NVO":"诺和诺德","NVAX":"诺瓦瓦克斯医药","JNJ":"强生","MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159455215","content_text":"The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid tariffs on pharma exports, according to people familiar with the matter.The clause doesn’t constitute a guarantee that Washington will hold off on putting tariffs on the industry considered vital by the Swiss, the people said, speaking on the condition of anonymity. They said the wording is framed as a pledge for both parties to cooperate to avoid such a move via the so-called Section 232 probe. The people cautioned that details are still being finalized and negotiations remain fluid until an announcement is ready.The draft also requires a nod from Donald Trump, while the Swiss government has already implicitly agreed, one of the people said. As soon as the US president signs off, formal approval from Bern would happen very quickly, they added.Switzerland is among several countries trying to negotiate a bilateral trade deal with the US to avoid an increase of Trump’s tariff of 10% to a higher level designated on April 2 — 31% in Switzerland’s case — when a 90-day reprieve expires on July 9. Being spared the threat of future pharma duties was one of the key asks from Swiss negotiators.Switzerland’s Economy Ministry declined to comment. A spokesman for the White House said that “discussion about any potential trade deal should be considered speculation unless officially announced by President Trump.”The Trump administration launched a probe in mid-April that could open the door to tariffs on pharmaceutical imports. Under the Section 232 investigation, the Commerce Department has as long as 270 days — or about nine months — to determine whether the foreign production of drugs is a threat to national security, though it can release the findings much more quickly.Switzerland is a major exporter of drugs to the US, with pharmaceuticals accounting for almost half of Swiss goods exports to America in 2024, according to data compiled by Bloomberg Economics. For companies including Novartis AG and Roche Holding AG, the US is the most profitable market, as is the case for many producers of medicines.Similar to provisions in a US-UK framework deal signed in May, the draft US-Switzerland pact also agrees that the Swiss will strive to meet US requirements for the security of supply chains. That’s a push for pharma companies no longer sourcing certain ingredients from China, one of the people said. The respective clause in the accord with the UK was publicly criticized by Chinese officials.","news_type":1,"symbols_score_info":{"NVO":1.1,"NVAX":1.1,"NVS":1.1,"LLY":1.1,"PFE":1.1,"MRK":1.1,"MRNA":1.1,"JNJ":1.1}},"isVote":1,"tweetType":1,"viewCount":1374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":452898935972616,"gmtCreate":1751596385111,"gmtModify":1751597471700,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"authorIdStr":"4214681225167932","idStr":"4214681225167932"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/452898935972616","repostId":"2548562388","repostType":2,"isVote":1,"tweetType":1,"viewCount":1483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":453398394003528,"gmtCreate":1751715253743,"gmtModify":1751717187509,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4214681225167932","authorIdStr":"4214681225167932"},"themes":[],"htmlText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a> ","listText":"<a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a><v-v data-views=\"1\"></v-v><a href=\"https://ttm.financial/S/MSFT\">$Microsoft(MSFT)$ </a> ","text":"$Microsoft(MSFT)$ $Microsoft(MSFT)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/453398394003528","isVote":1,"tweetType":1,"viewCount":1421,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":453173952565384,"gmtCreate":1751660628884,"gmtModify":1751664241117,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4214681225167932","authorIdStr":"4214681225167932"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/453173952565384","repostId":"1159455215","repostType":4,"repost":{"id":"1159455215","kind":"news","pubTimestamp":1751637548,"share":"https://ttm.financial/m/news/1159455215?lang=en_US&edition=fundamental","pubTime":"2025-07-04 21:59","market":"us","language":"en","title":"US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy","url":"https://stock-news.laohu8.com/highlight/detail?id=1159455215","media":"Bloomberg","summary":"The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid...","content":"<div>\n<p>The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy\">Source Link</a>\n\n</div>\n","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS-Swiss Trade Deal Likely to Contain Assurances on Pharma Levy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-04 21:59 GMT+8 <a href=https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVS":"诺华","PFE":"辉瑞","MRNA":"Moderna, Inc.","LLY":"礼来","NVO":"诺和诺德","NVAX":"诺瓦瓦克斯医药","JNJ":"强生","MRK":"默沙东"},"source_url":"https://www.bloomberg.com/news/articles/2025-07-04/us-swiss-trade-deal-likely-to-contain-assurances-on-pharma-levy","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1159455215","content_text":"The draft of a trade accord between the US and Switzerland contains a provision that the European country will receive preferred treatment in the ongoing national-security investigations to avoid tariffs on pharma exports, according to people familiar with the matter.The clause doesn’t constitute a guarantee that Washington will hold off on putting tariffs on the industry considered vital by the Swiss, the people said, speaking on the condition of anonymity. They said the wording is framed as a pledge for both parties to cooperate to avoid such a move via the so-called Section 232 probe. The people cautioned that details are still being finalized and negotiations remain fluid until an announcement is ready.The draft also requires a nod from Donald Trump, while the Swiss government has already implicitly agreed, one of the people said. As soon as the US president signs off, formal approval from Bern would happen very quickly, they added.Switzerland is among several countries trying to negotiate a bilateral trade deal with the US to avoid an increase of Trump’s tariff of 10% to a higher level designated on April 2 — 31% in Switzerland’s case — when a 90-day reprieve expires on July 9. Being spared the threat of future pharma duties was one of the key asks from Swiss negotiators.Switzerland’s Economy Ministry declined to comment. A spokesman for the White House said that “discussion about any potential trade deal should be considered speculation unless officially announced by President Trump.”The Trump administration launched a probe in mid-April that could open the door to tariffs on pharmaceutical imports. Under the Section 232 investigation, the Commerce Department has as long as 270 days — or about nine months — to determine whether the foreign production of drugs is a threat to national security, though it can release the findings much more quickly.Switzerland is a major exporter of drugs to the US, with pharmaceuticals accounting for almost half of Swiss goods exports to America in 2024, according to data compiled by Bloomberg Economics. For companies including Novartis AG and Roche Holding AG, the US is the most profitable market, as is the case for many producers of medicines.Similar to provisions in a US-UK framework deal signed in May, the draft US-Switzerland pact also agrees that the Swiss will strive to meet US requirements for the security of supply chains. That’s a push for pharma companies no longer sourcing certain ingredients from China, one of the people said. The respective clause in the accord with the UK was publicly criticized by Chinese officials.","news_type":1,"symbols_score_info":{"NVO":1.1,"NVAX":1.1,"NVS":1.1,"LLY":1.1,"PFE":1.1,"MRK":1.1,"MRNA":1.1,"JNJ":1.1}},"isVote":1,"tweetType":1,"viewCount":1374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":453399477670296,"gmtCreate":1751715325402,"gmtModify":1751717187030,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4214681225167932","authorIdStr":"4214681225167932"},"themes":[],"htmlText":"mona<a href=\"https://ttm.financial/S/BTBT\">$Bit Digital, Inc.(BTBT)$ </a><a href=\"https://ttm.financial/S/SNPS\">$Synopsys(SNPS)$ </a> ","listText":"mona<a href=\"https://ttm.financial/S/BTBT\">$Bit Digital, Inc.(BTBT)$ </a><a href=\"https://ttm.financial/S/SNPS\">$Synopsys(SNPS)$ </a> ","text":"mona$Bit Digital, Inc.(BTBT)$ $Synopsys(SNPS)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/453399477670296","isVote":1,"tweetType":1,"viewCount":1166,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":452898935972616,"gmtCreate":1751596385111,"gmtModify":1751597471700,"author":{"id":"4214681225167932","authorId":"4214681225167932","name":"Debit Card FAQ","avatar":"https://community-static.tradeup.com/news/7e6470bb81bfd06a87cc215708f50cdc","crmLevel":1,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4214681225167932","authorIdStr":"4214681225167932"},"themes":[],"htmlText":"Share your opinion about this news…","listText":"Share your opinion about this news…","text":"Share your opinion about this news…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/452898935972616","repostId":"2548562388","repostType":2,"repost":{"id":"2548562388","kind":"highlight","pubTimestamp":1751592059,"share":"https://ttm.financial/m/news/2548562388?lang=en_US&edition=fundamental","pubTime":"2025-07-04 09:20","market":"sg","language":"en","title":"4 Singapore Stocks Dishing Out Dividend Yields of 4.2% or More","url":"https://stock-news.laohu8.com/highlight/detail?id=2548562388","media":"The Smart Investor","summary":"Income investors can look to these four stocks that are providing attractive yields.","content":"<div>\n<p>Dividends represent a tangible return on your investment that is unaffected by the volatility of share prices.They also count as a useful stream of passive income that can sustain you through your ...</p>\n\n<a href=\"https://thesmartinvestor.com.sg/4-singapore-stocks-dishing-out-dividend-yields-of-4-2-or-more/\">Source Link</a>\n\n</div>\n","source":"thesmartinvestor_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>4 Singapore Stocks Dishing Out Dividend Yields of 4.2% or More</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n4 Singapore Stocks Dishing Out Dividend Yields of 4.2% or More\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-04 09:20 GMT+8 <a href=https://thesmartinvestor.com.sg/4-singapore-stocks-dishing-out-dividend-yields-of-4-2-or-more/><strong>The Smart Investor</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividends represent a tangible return on your investment that is unaffected by the volatility of share prices.They also count as a useful stream of passive income that can sustain you through your ...</p>\n\n<a href=\"https://thesmartinvestor.com.sg/4-singapore-stocks-dishing-out-dividend-yields-of-4-2-or-more/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK6509":"食品和饮料股","BK6101":"陆运","BK6051":"信息科技咨询与其它服务","C52.SI":"康福德高企业","SG9999014492.USD":"NIKKO AM ASEAN EQUITY \"A\" (USD) ACC","SG9999014484.SGD":"Nikko AM ASEAN Equity Fund A SGD","F03.SI":"富旺朝","BK6136":"旅客陆运","SG9999004360.SGD":"Nikko AM Shenton Thrift Fund SGD","SGXZ27511609.SGD":"NIKKO AM SINGAPORE DIVIDEND EQUITY \"SGD\" (SGD) ACC","SG9999003826.SGD":"日兴资管新加坡股息基金 SGD","BK6114":"包装食品与肉类","CC3.SI":"星和","BK6519":"运输股","SG9999006266.SGD":"MANULIFE SINGAPORE EQUITY \"A\" (SGD) ACC","544.SI":"CSE 环球","BK6508":"软件和IT服务概念","BK6048":"无线电信业务","BK6513":"电信服务股"},"source_url":"https://thesmartinvestor.com.sg/4-singapore-stocks-dishing-out-dividend-yields-of-4-2-or-more/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2548562388","content_text":"Dividends represent a tangible return on your investment that is unaffected by the volatility of share prices.They also count as a useful stream of passive income that can sustain you through your retirement.Luckily, Singapore’s stock market has a wide range of dividend-paying stocks that you can sift through to add to your buy watchlist.Here are four that are yielding 4.2% or higher.CSE Global (SGX: 544)CSE Global is a systems integrator that provides electrification, communications, and automation solutions to a variety of industries globally.The group has a presence in 15 countries with 61 offices and employs more than 2,000 staff.For 2024, CSE Global reported a solid set of earnings with revenue rising 18.8% year on year to S$861.2 million.Net profit soared 63.2% year on year to S$36.8 million.However, the group declared a final dividend of S$0.0115, down from the previous year’s S$0.015.Coupled with the interim dividend of S$0.0125, the total dividend for 2024 stood at S$0.024.Shares of CSE Global provide a trailing dividend yield of 4.2%.The engineering group released a mixed business update for the first quarter of 2025 (1Q 2025).Revenue inched up 4% year on year to S$205.5 million.However, order intake fell by 11.3% year on year to S$155.3 million.CSE Global’s order book tumbled 14.4% year on year to S$616 million.Management warned that the global economic outlook, along with inflationary pressures, could lead to continued market uncertainty.The group also concluded its acquisition of Chicago Communications, LLC at the end of April 2025.ComfortDelGro Corporation Limited (SGX: C52)ComfortDelGro Corporation, or CDG, is a multi-modal transport operator with a suite of transportation solutions.The group’s network covers public transport such as buses and rail, along with private hire cars and taxis spanning 13 countries.CDG reported a solid set of earnings for 2024 with revenue rising 15.4% year on year to S$4.5 billion.Operating profit climbed 18.7% year on year to S$322.9 million while net profit increased by 16.6% year on year to S$210.5 million.A final dividend of S$0.0425 was declared and paid, up 13% year on year.The total dividend for 2024 stood at S$0.077, up nearly 17% year on year, giving shares of CDG a trailing dividend yield of 5.3%.The land transport giant released an encouraging business update for 1Q 2025.Revenue shot up 16.4% year on year to S$1.17 billion, lifted by the acquisitions of A2B and Addison Lee in 2024.Operating profit leapt 45.5% year on year to S$81.5 million, and net profit increased by 19% year on year to S$48.3 million.CDG recently commenced a two-year pilot program to deploy commercial robotaxi services in Guangzhou, China.StarHub (SGX: CC3)StarHub is one of the three major telecommunication companies (telcos) in Singapore, and offers a range of services such as mobile, Pay TV, and broadband.For 2024, StarHub reported a slight 0.2% year-on-year dip in total revenue to S$2.4 billion.Net profit improved by 7.3% year on year to S$160.5 million.A final dividend of S$0.032 was declared, taking the total 2024 dividend to S$0.062, which exceeded management’s guidance of “at least S$0.06”.StarHub’s shares provide a trailing dividend yield of 5.3%.The telco expects its enterprise managed services and regional ICT services divisions to post growth for 2025.Cash generation capability is expected to stay robust for the rest of this year, with the total dividend to be the higher of S$0.06 or 80% of net attributable profit (excluding one-offs).1Q 2025 saw a downbeat set of earnings from StarHub.Service revenue dipped slightly to S$464 million, but net profit tumbled 18.4% year on year to S$31.8 million because of higher depreciation and amortisation.The telco aims to grow its consumer market share, scale its regional enterprise, and pursue acquisitive growth.Food Empire (SGX: F03)Food Empire is a food and beverage manufacturer with a portfolio spanning snack foods, instant beverages, and food ingredients.The group owns nine manufacturing facilities in six countries and boasts proprietary brands such as MacCoffee, CafePHO, and Hillway.Food Empire reported a mixed set of earnings for 2024.Total revenue rose almost 12% year on year to US$476.3 million, representing its fourth consecutive year of topline growth.However, net profit declined by 11.4% (excluding exceptional items) to US$50 million.The board proposed and paid out a total dividend of S$0.08, consisting of a first and final dividend of S$0.06 and a special dividend of S$0.02.Shares of Food Empire provide a trailing dividend yield of 4.3%.The instant beverage manufacturer kicked off a strong start to 2025.For 1Q 2025, the business registered a 16.3% year-on-year growth in total revenue to US$136.6 million.The group will establish a new freeze-dried soluble coffee manufacturing facility in Binh Dinh province.Construction will begin by the end of 2025, and this facility should be completed by 2028.","news_type":1,"symbols_score_info":{"544.SI":1,"C52.SI":1,"CC3.SI":1,"F03.SI":1}},"isVote":1,"tweetType":1,"viewCount":1483,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}